Acceleron Pharma teams up with Fulcrum Therapeutics in pulmonary diseases [Seeking Alpha]
Acceleron Pharma Inc. (XLRN)
Last acceleron pharma inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.acceleronpharma.com/investor-relations
Company Research
Source: Seeking Alpha
Healthcare Acceleron Pharma teams up with Fulcrum Therapeutics in pulmonary diseases Dec. 30, 2019 9:41 AM ET | Acceleron Pharma Inc. (XLRN) Douglas W. House Acceleron Pharma ( -0.7% agreement FULC The partnership will leverage Fulcrum's know-how in identifying drug targets based on genetic pathway modulation with Acceleron's expertise in TGF-beta superfamily signaling. Acceleron will have access to Fulcrum's proprietary product engine and target identification platform and will be responsible for all development and commercialization activities for identified candidates. Under the terms of the agreement, Fulcrum will receive $10M upfront, up to $295M in milestones for the first commercialized product, up to $143.5M in milestones for subsequent products and mid-single-digit-to-low-double-digit royalties on net sales. Click to subscribe to real-time analytics on XLRN Now read: Myriad up 6% premarket on FDA nod for test as Lynparza companion diagnostic » Try PREMIUM
Show less
Read more
Impact Snapshot
Event Time:
XLRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XLRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XLRN alerts
High impacting Acceleron Pharma Inc. news events
Weekly update
A roundup of the hottest topics